•
Jun 30, 2018

Outlook Therapeutics Q3 2018 Earnings Report

Total Revenue
$772K
Previous year: $303K
+154.6%
EPS
-$4
Previous year: -$4
+0.0%
Gross Profit
$0
0
Cash and Equivalents
$11.8M
Previous year: $140K
+8332.3%
Free Cash Flow
-$8.7M
Previous year: -$15.7M
-44.4%
Total Assets
$34.1M
Previous year: $17.1M
+99.0%

Outlook Therapeutics

Outlook Therapeutics